Log in Book a Demo

US Pharma & Biotech Research and Development - PPC Market Share Analysis May 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Research and Development category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Research and Development – US

Google AI Overview visibility for Pharma & Biotech Research and Development US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 65.3437565997
34.6562434003
65%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 16
84
16%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 4%
Transactional 2%
Navigational 5%
Seasonal 0%
Local 0%
Problem Solving 15%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Research and Development brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
lilly.com 24.82
ro.co 7.67
regeneron.com 6.68
gsk.com 6.1
ziphealth.co 4.53
abbvie.com 4.11
pfizerforall.com 3.65
merck.com 3.56
sequencing.com 2.95
rugiet.com 1.91
others 34.02
  • lilly.com - 24.82%
  • ro.co - 7.67%
  • regeneron.com - 6.68%
  • gsk.com - 6.1%
  • ziphealth.co - 4.53%
  • abbvie.com - 4.11%
  • pfizerforall.com - 3.65%
  • merck.com - 3.56%
  • sequencing.com - 2.95%
  • rugiet.com - 1.91%
  • others - 34.02%

Copyright © Adthena. All rights reserved.

In the PPC landscape, Lilly.com leads with 24.82% click share, while ‘others’ collectively hold 34.02%, showcasing diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Research and Development brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Share of Spend - Last Month
Date lilly.com ro.co ziphealth.co pfizerforall.com evenity.com rugiet.com scemblix.com hims.com malemd.com redboxrx.com
2026/05/01 26.75% 15.46% 6.92% 4.73% 1.76% 2.54% 0.92% 2.05% 1.39% 0.85%
2026/05/02 29.54% 12.59% 5.86% 5.12% 2.11% 2.97% 1.03% 1.21% 2.03% 1.12%
2026/05/03 20.73% 13.24% 7.58% 3.9% 2.08% 3.24% 1.07% 1.92% 1.6% 0.49%
2026/05/04 19.2% 12.68% 9.87% 5.18% 4.01% 3.24% 2.45% 1.78% 1.47% 0.5%
2026/05/05 20.67% 14.46% 7.53% 4.9% 3.82% 3.39% 1.62% 1.44% 0.97% 0.46%
2026/05/06 19.76% 11.25% 6.31% 4.58% 4.57% 4.04% 2.55% 2.51% 1.26% 1.54%
2026/05/07 26.97% 12.49% 5.87% 6.94% 3.63% 2.78% 1.83% 0.97% 1.09% 1.2%
2026/05/08 27.55% 14.64% 5.26% 5.06% 3.09% 2.15% 1.14% 2.32% 1.19% 1.12%
2026/05/09 27.55% 11.75% 6.44% 5.02% 3.62% 2.98% 1.96% 2.4% 1.63% 0.8%
2026/05/10 28.09% 12.42% 8.14% 3.82% 1.97% 2.28% 1.72% 2.23% 1.7% 1.12%
2026/05/11 20.97% 14.02% 7.35% 5.63% 2.85% 3.26% 1.12% 1.6% 1.97% 1.52%
2026/05/12 22.27% 14.71% 5.07% 5.53% 4.15% 2.81% 1.78% 2.63% 1.48% 1.51%
2026/05/13 20.27% 9.38% 8.07% 5.33% 1.31% 4.35% 0.69% 2.73% 2.18% 2.98%
2026/05/14 25.14% 14.89% 6.02% 4.4% 3.74% 3.13% 1.41% 1.3% 1.47% 1.68%
2026/05/15 27.5% 14.62% 5.25% 5.05% 3.08% 2.15% 1.14% 2.31% 1.18% 1.11%
2026/05/16 28.53% 15.49% 5.83% 4.16% 3.09% 3.42% 2% 0.93% 1.75% 2.17%
2026/05/17 29.9% 10.98% 5.54% 5.46% 2.29% 3.26% 2.24% 2.1% 1.96% 2.05%
2026/05/18 23.76% 14.77% 5.8% 6.11% 3.6% 2.79% 1.66% 2.49% 1.2% 1.71%
2026/05/19 21.37% 16.77% 7.71% 5.99% 2.06% 4.48% 2.2% 1.13% 1.71% 1.61%
2026/05/20 28.11% 13.96% 3.41% 5.93% 2.9% 2.47% 2.47% 2.11% 1.45% 1.26%
2026/05/21 20.83% 15.89% 8% 5.79% 3.37% 4.46% 1.99% 1.25% 1.42% 1.41%
2026/05/22 26.54% 13.14% 6.25% 6.1% 3.77% 2.6% 2.23% 2.53% 1.33% 1.34%
2026/05/23 29.95% 8.16% 7.39% 5.27% 1.27% 3.5% 2.21% 2.76% 1.46% 1.65%
2026/05/24 30.57% 9.55% 5.73% 5.94% 3.66% 2.53% 2.13% 2.01% 1.17% 1.51%
2026/05/25 29.09% 12.34% 7.12% 5.2% 2.37% 1.92% 2.07% 3.24% 1.15% 2.1%
2026/05/26 27.64% 9.07% 7% 6.02% 3.14% 2.15% 1.94% 1.93% 1.45% 1.55%
2026/05/27 21.48% 10.57% 6.67% 6.89% 3.21% 2.21% 2.24% 2.53% 1.23% 1.59%
2026/05/28 28.1% 7.69% 5.76% 6.11% 4.16% 2.38% 1.89% 2.54% 0.6% 1.08%
2026/05/29 26.59% 7.99% 2.42% 6.76% 2.17% 1.17% 1.27% 2.84% 0.28% 0.6%
2026/05/30 25.41% 10.35% 4.77% 5.3% 2.59% 2.71% 1.21% 1.61% 1.33% 1.6%
2026/05/31 28.62% 11.73% 5.94% 4.41% 2.79% 2.1% 1.89% 1.5% 1.16% 1.08%
  • lilly.com
  • ro.co
  • ziphealth.co
  • pfizerforall.com
  • evenity.com
  • rugiet.com
  • scemblix.com
  • hims.com
  • malemd.com
  • redboxrx.com

Copyright © Adthena. All rights reserved.

Lilly.com led May with fluctuating spend, peaking at 30.57%. Ro.co’s share dipped, while Ziphealth.co and Pfizerforall.com showed steady patterns. Evenity.com and Rugiet.com had minor variations. Scemblix.com, Hims.com, Malemd.com, and Redboxrx.com maintained low shares.

Market Exposure

Competitor Count for US Pharma & Biotech Research and Development

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/05/01 446
2026/05/02 433
2026/05/03 441
2026/05/04 452
2026/05/05 466
2026/05/06 449
2026/05/07 449
2026/05/08 461
2026/05/09 444
2026/05/10 456
2026/05/11 476
2026/05/12 481
2026/05/13 470
2026/05/14 481
2026/05/15 461
2026/05/16 491
2026/05/17 478
2026/05/18 499
2026/05/19 470
2026/05/20 450
2026/05/21 485
2026/05/22 477
2026/05/23 453
2026/05/24 462
2026/05/25 494
2026/05/26 496
2026/05/27 472
2026/05/28 479
2026/05/29 473
2026/05/30 473
2026/05/31 477

Copyright © Adthena. All rights reserved.

In May 2026, advertiser numbers fluctuated, peaking at 499 on May 18. The month concluded with 477 advertisers, reflecting dynamic competition.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Research and Development

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
lilly.com 1.35%
pfizerforall.com 0.62%
regeneron.com 0.55%
gsk.com 0.42%
exactsciences.com 0.39%
lifemd.com -0.37%
abbvie.com -0.45%
medchemexpress.com -0.64%
wegovy.com -0.91%
ro.co -1.37%

Copyright © Adthena. All rights reserved.

Lilly.com surged with a 1.35% click share increase, while ro.co faced a 1.37% decline.

Campaign Efficiency

US Pharma & Biotech Research and Development Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date lilly.com ro.co ziphealth.co regeneron.com pfizerforall.com merck.com rugiet.com gsk.com abbvie.com hims.com
2026/05/01 16.44% 18.39% 7.02% 3.45% 4.08% 2.49% 2.84% 1.84% 2.06% 2.13%
2026/05/02 17.28% 15.6% 5.9% 1.96% 4.33% 1.63% 3.32% 1.51% 5.54% 1.19%
2026/05/03 12.84% 15.17% 7.38% 4.55% 3.31% 1.83% 3.47% 1.67% 3.71% 1.91%
2026/05/04 12.32% 13.98% 9.35% 3.02% 4.27% 2.5% 3.39% 2.03% 1.53% 2.01%
2026/05/05 13.35% 16.82% 7.26% 2.12% 4.22% 2.05% 3.62% 1.89% 0.64% 1.5%
2026/05/06 11.35% 15.41% 6.12% 3.17% 3.72% 3.07% 4.32% 2.52% 1.09% 3.01%
2026/05/07 16.78% 17.21% 5.83% 2.11% 6.41% 1.75% 3.04% 2.55% 1.58% 0.95%
2026/05/08 16.42% 18% 5.35% 2.39% 4.38% 1.94% 2.43% 2.14% 1.69% 2.4%
2026/05/09 16.87% 12.79% 6.19% 3.18% 4.32% 2.06% 3.16% 1.92% 6.13% 2.28%
2026/05/10 16.92% 13.47% 7.96% 1.63% 3.25% 2.43% 2.47% 1.95% 4.81% 2.47%
2026/05/11 13.9% 14.68% 6.8% 2.78% 4.37% 2.1% 3.32% 1.66% 0.53% 1.43%
2026/05/12 13.47% 18.15% 4.76% 2.51% 4.74% 2.89% 2.92% 1.54% 1.34% 2.61%
2026/05/13 11.94% 11.06% 7.21% 1.94% 3.83% 2.1% 4.32% 1.6% 1.9% 2.36%
2026/05/14 14.85% 18.19% 5.59% 2.43% 3.59% 2.42% 3.22% 1.96% 1.92% 1.17%
2026/05/15 16.42% 18% 5.35% 2.39% 4.38% 1.94% 2.43% 2.14% 1.69% 2.4%
2026/05/16 19.32% 17.72% 5.65% 1.71% 3.46% 2.45% 3.67% 1.84% 3.27% 0.98%
2026/05/17 18.08% 13.77% 5.39% 1.84% 4.5% 2.39% 3.49% 2.06% 3.24% 1.98%
2026/05/18 15.91% 15.22% 5.52% 0.83% 4.95% 2.13% 2.89% 2.52% 2.25% 2.6%
2026/05/19 13.15% 19.96% 7.19% 0.71% 4.54% 2.08% 4.64% 1.91% 0.57% 1.02%
2026/05/20 17.64% 17.46% 3.32% 1.69% 4.93% 2.59% 2.62% 2.27% 1.04% 2.65%
2026/05/21 13.11% 18.7% 7.45% 2.02% 5% 2.45% 4.61% 2.03% 1.6% 1.12%
2026/05/22 17.47% 15.08% 6.05% 1.96% 5.34% 1.71% 2.79% 2.17% 1.76% 2.51%
2026/05/23 20.01% 8.81% 7.2% 4.63% 4.54% 3.03% 3.76% 1.72% 4.13% 2.9%
2026/05/24 19.7% 10.6% 5.5% 1.21% 5.32% 2.94% 2.68% 2.23% 5.05% 2.07%
2026/05/25 18.98% 13.14% 7.05% 2.11% 4.59% 1.61% 2.1% 1.8% 1.31% 3.44%
2026/05/26 19% 10.21% 6.81% 2.45% 5.35% 1.93% 2.32% 2.17% 0.1% 2.09%
2026/05/27 14.35% 11.81% 6.14% 1.86% 6.17% 2.65% 2.25% 1.8% 1.38% 2.47%
2026/05/28 18.2% 8.34% 5.61% 1.8% 5.85% 1.41% 2.58% 2.12% 2.59% 2.68%
2026/05/29 17.18% 8.21% 2.39% 2.54% 6.15% 1.59% 1.29% 2.75% 2.65% 3.24%
2026/05/30 15.8% 11.09% 4.53% 4.05% 4.68% 1.6% 2.83% 1.84% 2.52% 1.52%
2026/05/31 17.29% 13.25% 5.91% 4.09% 4% 3.05% 2.34% 2.06% 2.04% 1.65%
  • lilly.com
  • ro.co
  • ziphealth.co
  • regeneron.com
  • pfizerforall.com
  • merck.com
  • rugiet.com
  • gsk.com
  • abbvie.com
  • hims.com

Copyright © Adthena. All rights reserved.

In May 2026, lilly.com saw fluctuating impressions, peaking at 20.01% on the 23rd. Ro.co’s share dropped significantly after mid-month, while ziphealth.co remained steady. Regeneron.com and pfizerforall.com showed minor variations. Merck.com and rugiet.com had consistent shares, with gsk.com and abbvie.com experiencing slight increases. Hims.com ended the month with a modest rise.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Research and Development

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Research and Development - Last month
  1. 1
    AbbVie Inc - A Biopharmaceutical Company https://www.abbvie.com/

    Find The Company's Mission, Principles & Culture. See What We Do Beyond Treating Diseases.

  2. 2
    Get Wegovy Online - Unlimited Care For $39/mo https://www.goodrx.com/

    FDA approved Wegovy prescriptions starting as low as $149/mo plus $39/mo subscription.

  3. 3
    Lilly - A Medicine Company https://www.lilly.com

    Learn About A Medicine Company — We're in The Business of Health. Lilly - A Medicine Company.

  4. 4
    PfizerForAll™ | Welcome To Patient Resources https://www.pfizerforall.com

    Welcome to PfizerForAll. Answers and Care, All In One Place. Information You Can Access Right Now. Visit PfizerForAll To Learn More.

  5. 5
    Eli Lilly's Zepbound - Lowest Price, Guaranteed https://www.ro.co/zepbound/vials

    Ongoing reqd membership & med cost vary. See Rx warning.

Copyright © Adthena. All rights reserved.

In the competitive landscape of pharmaceuticals, AbbVie emphasizes its mission and culture, while GoodRx offers affordable Wegovy prescriptions. Lilly positions itself as a health-centric company, Pfizer provides comprehensive patient resources, and Ro.co guarantees the lowest price for Eli Lilly’s Zepbound.

Frequently Asked Questions

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

Related reports

UK
Pharma & Biotech

UK Research and Development

AUS